This announcement is a separate document:
康弘药业：北京市通商（深圳）律师事务所关于成都康弘药业集团股份有限公司2021年股票期权激励计划注销部分股票期权的法律意见书
Kanghong Pharmaceutical: Legal Opinion of Beijing Commerce (Shenzhen) Law Firm on Cancellation of Part of the Stock Options Incentive Plan of Chengdu Kanghong Pharmaceutical Group Co., Ltd. in 2021 Stock Option Incentive Plan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated